Latest News - Acne

Wednesday, July 11, 2018

Fourth Generation Retinoid Shows Promise in Acne Trials

New research reveals that trifarotene, a fourth-generation retinoid with potent and selective activity against only one particular retinoic acid receptor, may have an improved efficacy and safety prof…

Read the full story

Tuesday, June 19, 2018

New Patient-Centered Panel Helps BioPharmX Define its Role in the Future of Dermatology

BioPharmX Corporation has formed a Special Advisory Council of thought leaders from various disciplines to help the company embrace patient centricity in its products, pricing, and market access consi…

Read the full story

Monday, June 04, 2018

Spironolactone May Be an Alternative to Antibiotics in Female Acne

The diuretic drug spironolactone may be just as effective as antibiotics for the treatment of women’s acne, report researchers from the Perelman School of Medicine at the University of Pennsylva…

Read the full story

Friday, May 11, 2018

Valeant is Becoming Bausch Health Companies, Inc.

Bausch Health Companies, Inc. will become the new name of Valeant Pharmaceuticals International, Inc., effective in July 2018. Based on the strong brand equity of the company’s businesses a…

Read the full story

Monday, April 30, 2018

New Phase 4 Data: Epiduo Forte Gel Decreased Acne Lesions, Reduced Risk of Scars

Results from OSCAR, a Phase 4, multicenter, randomized, investigator-blinded, vehicle-controlled, intra-individual comparison study (right/left half-face), revealed that Epiduo Forte (adapalene a…

Read the full story

Friday, April 27, 2018

Acne Survey at Twins Convention Affirms Genetic Link

A survey of identical and fraternal twin pairs at the Twins Days Festival in Twinsburg, OH, and published in the April issue of the Journal of Drugs in Dermatology, shows acne may be primarily caused …

Read the full story

Tuesday, March 27, 2018

Skin of Color Society Reports Banner Year

Kudos to the Skin of Color Society (SOCS) for a banner year. At its recent annual business meeting held in conjunction with the 2018 Annual Meeting of the American Academy of Dermatology, SOCS…

Read the full story

Tuesday, March 06, 2018

Differin Launches Retinoid Education Week

Differin® has launched Retinoid Education Week to educate the more than 50 million Americans with acne about how retinoids can be used to treat their condition. Part of Nestlé Skin Health&r…

Read the full story

Thursday, March 01, 2018

Calling All Students: Ortho Dermatologics Now Accepting Applications for the 2018 Aspire Higher Scholarship Program

Ortho Dermatologics is accepting applications for the 2018 Aspire Higher scholarship program for students who have been affected by dermatologic conditions. Through the program, nine students will …

Read the full story

Thursday, February 22, 2018

Vit D Levels Elevated in Acne

Levels of vitamin D are higher in acne patients, compared to age/sex matched controls. Researchers found a significant inverse relation between level of 25 hydroxy vitamin D and severity of acne vulga…

Read the full story

Wednesday, February 07, 2018

Research Finds Acne Linked with Increased Risk of Depression

In an analysis of one of the largest electronic medical records databases in the world, researchers found that patients with acne had a significantly increased risk of developing major depression, but…

Read the full story

Monday, January 22, 2018

Retin-A Micro Gel Microsphere 0.06% Now Available from Ortho Dermatologics to Treat Acne

Retin-A Micro (tretinoin) gel microsphere 0.06% is now available commercially to healthcare professionals. The FDA approved Ortho Dermatologics' Supplemental New Drug Application (sNDA) for Retin-…

Read the full story

Friday, January 12, 2018

FDA Accepts Ortho Dermatologics' Filing for IDP-121 Acne Treatment In Lotion Form

The FDA has accepted  Ortho Dermatologics' New Drug Application for IDP-121 (tretinoin 0.05%) lotion (Altreno) with a PDUFA action date of Aug. 27, 2018. If approved, Altreno will be the firs…

Read the full story

Wednesday, December 20, 2017

FDA Accepts NDA for Allergan, Paratek Acne Drug

The U.S. Food and Drug Administration accepted a New Drug Application (NDA) to review SeysaraTM(sarecycline) for the treatment of moderate to severe acne vulgaris in patients 9 years of age and older,…

Read the full story

Thursday, December 14, 2017

Acne Anxiety Dampens Teen Social Media Use

Teens with acne report a negative impact on their body image and self-esteem, and this translates into anxiety over using social media, mainly the online posting of photos, videos and "…

Read the full story
Load More